Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 958 | 854 | 958 | 811 | 1059 | - |
Fund Return | -4.19% | -14.63% | -4.19% | -6.75% | 1.16% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2197358042 | 3.15B | 32.38 | 11.21 | - | ||
Cleome Index USA Equities R EUR Acc | 3.15B | 32.09 | 10.97 | 13.80 | ||
Cleome Index USA Equities Y EUR Acc | 3.15B | 30.72 | 9.80 | 12.92 | ||
Cleome Index USA Equities Z EUR Acc | 3.15B | 32.48 | 11.30 | 14.20 | ||
Candriam Equities L Global Demograp | 2.18B | 22.09 | 6.38 | 10.99 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 69.87B | 15.41 | 9.09 | 7.73 | ||
Invesco JapEqAdvantage C EUR H AccE | 69.87B | 16.34 | 10.03 | 8.58 | ||
LU1841614867 | 275.45M | 18.68 | 8.34 | - | ||
LU1482751903 | 480.5M | 19.62 | 9.30 | - | ||
Morgan Stanley Global Brands CH | 20.91B | 5.17 | -2.52 | 6.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.45 | 804.08 | -0.11% | |
Merck&Co | US58933Y1055 | 4.89 | 98.28 | +0.85% | |
Novo Nordisk B | DK0062498333 | 4.45 | 607.7 | -0.51% | |
Roche Holding Participation | CH0012032048 | 4.40 | 280.80 | +0.18% | |
Regeneron Pharma | US75886F1075 | 4.10 | 687.27 | +0.14% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Sell | Sell |
Summary | Strong Buy | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review